Peter S Aronson
Overview
Explore the profile of Peter S Aronson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1987
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brosecke F, Pfau A, Ermer T, Dein Terra Mota Ribeiro A, Rubenbauer L, Rao V, et al.
Sci Rep
. 2024 May;
14(1):11323.
PMID: 38760468
Oxalate, a uremic toxin that accumulates in dialysis patients, is associated with cardiovascular disease. As oxalate crystals can activate immune cells, we tested the hypothesis that plasma oxalate would be...
2.
Pfau A, Lopez-Cayuqueo K, Scherer N, Wuttke M, Wernstedt A, Gonzalez Fassrainer D, et al.
J Clin Invest
. 2023 Jan;
133(3).
PMID: 36719378
Sulfate plays a pivotal role in numerous physiological processes in the human body, including bone and cartilage health. A role of the anion transporter SLC26A1 (Sat1) for sulfate reabsorption in...
3.
Ermer T, Nazzal L, Tio M, Waikar S, Aronson P, Knauf F
Nat Rev Nephrol
. 2022 Nov;
19(2):123-138.
PMID: 36329260
Oxalate homeostasis is maintained through a delicate balance between endogenous sources, exogenous supply and excretion from the body. Novel studies have shed light on the essential roles of metabolic pathways,...
4.
5.
6.
Corniere N, Thomson R, Thauvin S, Villoutreix B, Karp S, Dynia D, et al.
J Med Genet
. 2022 Feb;
59(11):1035-1043.
PMID: 35115415
Background: Nephrolithiasis (NL) is a complex multifactorial disease affecting up to 10%-20% of the human population and causing a significant burden on public health systems worldwide. It results from a...
7.
Pfau A, Ermer T, Coca S, Tio M, Genser B, Reichel M, et al.
J Am Soc Nephrol
. 2021 Jul;
32(9):2375-2385.
PMID: 34281958
Background: The clinical significance of accumulating toxic terminal metabolites such as oxalate in patients with kidney failure is not well understood. Methods: To evaluate serum oxalate concentrations and risk of...
8.
Pfau A, Wytopil M, Chauhan K, Reichel M, Coca S, Aronson P, et al.
Kidney Int Rep
. 2021 Apr;
6(4):1194-1195.
PMID: 33912771
No abstract available.
9.
Pfau A, Wytopil M, Chauhan K, Reichel M, Coca S, Aronson P, et al.
Kidney Int Rep
. 2020 Nov;
5(11):2013-2020.
PMID: 33163722
Introduction: Alterations in oxalate homeostasis are associated with kidney stone disease and progression of chronic kidney disease (CKD). However, accurate measurement of plasma oxalate (P) concentrations in large patient cohorts...
10.
Neumeier L, Thomson R, Reichel M, Eckardt K, Aronson P, Knauf F
J Am Soc Nephrol
. 2020 Jul;
31(9):1987-1995.
PMID: 32660969
Background: A state of oxalate homeostasis is maintained in patients with healthy kidney function. However, as GFR declines, plasma oxalate (P) concentrations start to rise. Several groups of researchers have...